Three NIH Scientists Elected to Institute of Medicine
News Oct 22, 2013
Three scientists at the National Institutes of Health have been elected members of the Institute of Medicine. Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Current, active IOM membership elects new members annually from candidates nominated for professional achievement and commitment to service. For 2013, 70 new members were chosen.
"Election to the IOM is a marker of an outstanding professional and scientific career," said NIH Director Francis S. Collins, M.D., Ph.D. "We are proud of our accomplished scientists and congratulate them on this honor."
The NIH scientists newly elected are:
• Warren J. Leonard, M.D., National Heart, Lung and Blood Institute (NHLBI), is an NIH Distinguished Investigator, and chief of the Laboratory of Molecular Immunology and director of the Immunology Center at the National Heart, Lung, and Blood Institute. His research focuses on the biology, signaling, and molecular regulation of molecules known as cytokines, which are critical for the development and function of the immune system. He has made contributions in basic and applied research, including identifying the molecular cause of several forms of human inherited immunodeficiency. Dr. Leonard received his A.B. in mathematics, magna cum laude and Phi Beta Kappa, from Princeton University, Princeton, N.J., in 1973 and his M.D. from Stanford University, Stanford, Calif., in 1977.
• Ronald N. Germain, M.D., Ph.D., National Institute of Allergy and Infectious Diseases (NIAID), is an NIH Distinguished Investigator and chief of Laboratory Systems of Biology and the Lymphocyte Biology Section at NIAID. He has made seminal contributions to our understanding of T-cell receptor signaling in response to peptide/MHC molecule binding, the control of immune cell migration and cell-cell interaction in vivo by structural and chemical cues, and helped pioneer the field of intravital imaging, analysis, and modeling of immune cell dynamics. Dr. Germain has been at NIH since 1982 and received his Sc.B., summa cum laude, together with his Sc.M. from Brown University, Providence, R.I., in 1970. He earned his M.D., magna cum laude, together with his Ph.D. from Harvard Medical School and Harvard University, Cambridge, Mass., in 1976.
• Daniel S. Pine, M.D., National Institute of Mental Health (NIMH), is the chief of the Section on Development and Affective Neuroscience in the NIMH Intramural Research Program. After graduating from medical school at the University of Chicago in 1990, Dr. Pine spent 10 years in training and research on child psychiatry at the College of Physicians and Surgeons of Columbia University, New York City. Since medical school, he has been engaged continuously in research focusing on the epidemiology, biology, and treatment of pediatric mental illnesses. His areas of expertise include biological and pharmacological aspects of mood, anxiety, and behavioral disorders in children, as well as classification of psychopathology across the lifespan. This expertise is reflected in more than 300 peer-reviewed papers. Currently, his research group is examining the degree to which mood and anxiety disorders in children and adolescents are associated with underlying abnormalities in the amygdala, prefrontal cortex, and associated brain regions.
Human Malaria Parasites Grown for the First Time in Dormant FormNews
One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.READ MORE
Gut Bacteria Latest Ally in Fight Against SepsisNews
Sepsis occurs when the body's response to the spread of bacteria or toxins to the bloodstream damages tissues and organs. The fight against sepsis could get a helping hand from a surprising source: gut bacteria. Researchers found that giving mice particular microbes increased blood levels of immunoglobulin A (IgA) antibodies, which protected against the kind of widespread bacterial invasion that leads to sepsis.READ MORE